Author
Unnikrishnan is currently Senior Associate Editor with BW Businessworld at its Mumbai Bureau. During his two decades long journalistic career, he has received several media awards and recognitions. His articles on healthcare, life sciences and intellectual property rights (IPR) have been republished by several international blogs and journals.
Drug maker Glenmark and Evestra Inc, a San Antonio-based biopharmaceutical research and development company with focus in women’s healthcare, have signed a licensing and commercialization agreement for development and marketing of a generic version of Merck & Co.’s NuvaRing, for the US market
Read More
US-based defence technology and research leader Raytheon Company has signed a memorandum of understanding with Tata Advanced Systems to jointly produce Stinger air defence missile component
Read More
The proposal to merge state-owned oil & gas companies to create a single, unified giant has raised many eyebrows, and hackles
Read More
Piramal Fund Management has sanctioned investments worth approximately Rs 2,000 crore within three months of launching its Flexi Lease Rental Discounting for completed commercial assets that include office and retail space across the country
Read More
The patent challenges could remove barriers to production and distribution of affordable generic versions of direct-acting antiviral medicines, which are currently sold at very high prices
Read More
Independent observations of the Tata-Mistry tussle indicate that the reputation of the 78-year-old patriarch has now been shredded
Read More
Trump’s interventionist approach can negatively impact the Indian pharma industry, which is heavily dependent on the US market
Read More
The Union Budget-2017 proposal to drastically amend the Drugs and Cosmetics Act to enable availability and affordability of cheaper generic drugs to patients is expected to have key impacts on the local drug industry
Read More
State Bank of India (SBI) takes the lead yet again this year in announcing rate cuts and systemic restructuring
Read More
After weathering a few storms, Mahindra & Mahindra, is all set for a phase of rapid growth and investments
Read More
